If you made any changes in Pure these will be visible here soon.

Research Output

Article

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells

Sobrero, A. F., Aschele, C., Guglielmi, A. P., Mori, A. M., Melioli, G. G., Rosso, R. & Bertino, J. R., 1993, In : Journal of the National Cancer Institute. 85, 23, p. 1937-1944 8 p.

Research output: Contribution to journalArticle

Talking 'Tomudex': introduction.

Sobrero, A., Aug 1997, In : Anti-Cancer Drugs. 8 Suppl 2

Research output: Contribution to journalArticle

Talking 'Tomudex' Madrid, 19 April 1997. Introduction

Sobrero, A., 1997, In : Anti-Cancer Drugs. 8, SUPPL. 2

Research output: Contribution to journalArticle

Tamoxifen-induced total alopecia [5]

Puglisi, F., Aprile, G. & Sobrero, A., Jun 19 2001, In : Annals of Internal Medicine. 134, 12, p. 1154-1155 2 p.

Research output: Contribution to journalArticle

TAS-102 in refractory colorectal cancer: Caution is needed

Sobrero, A., Oct 2012, In : The Lancet Oncology. 13, 10, p. 959-961 3 p.

Research output: Contribution to journalArticle

Taxane-induced nail changes: Incidence, clinical presentation and outcome

Minisini, A. M., Tosti, A., Sobrero, A. F., Mansutti, M., Piraccini, B. M., Sacco, C. & Puglisi, F., Feb 1 2003, In : Annals of Oncology. 14, 2, p. 333-337 5 p.

Research output: Contribution to journalArticle

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

van Cutsem, E., Dicato, M., Geva, R., Arber, N., Bang, Y., Benson, A., Cervantes, A., Diaz-Rubio, E., Ducreux, M., Glynne-Jones, R., Grothey, A., Haller, D., Haustermans, K., Kerr, D., Nordlinger, B., Marshall, J., Minsky, B. D., Kang, Y. K., Labianca, R., Lordick, F. & 9 others, Ohtsu, A., Pavlidis, N., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J., van de Velde, C. & Zalcberg, J., 2011, In : Annals of Oncology. 22, SUPPL. 5

Research output: Contribution to journalArticle

The diagnosis and management of rectal cancer: Expert discussion and recommendations derived from the 9th world congress on gastrointestinal cancer, Barcelona, 2007

Van Cutsem, E., Dicato, M., Haustermans, K., Arber, N., Bosset, J. F., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Goldberg, R., Glynne-Jones, R., Haller, D., Kang, Y. K., Kerr, D., Labianca, R., Minsky, B. D., Moore, M., Nordlinger, B., Rougier, P., Scheithauer, W. & 6 others, Schmoll, H. J., Sobrero, A., Tabernero, J., Tempero, M., Van de Velde, C. & Zalcberg, J., Jun 2008, In : Annals of Oncology. 19, SUPPL. 6

Research output: Contribution to journalArticle

The handling of metastatic colorectal cancer

Fornarini, G., Guglielmi, A. & Sobrero, A., 2005, In : Annals of Oncology. 16, SUPPL. 2

Research output: Contribution to journalArticle

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

Sobrero, A., Grothey, A., Iveson, T., Labianca, R., Yoshino, T., Taieb, J., Maughan, T., Buyse, M., André, T., Meyerhardt, J., Shields, A. F., Souglakos, I., Douillard, J. Y. & Cervantes, A., May 1 2018, In : Annals of Oncology. 29, 5, p. 1099-1107 9 p.

Research output: Contribution to journalArticle

The IDEA (international duration evaluation of adjuvant chemotherapy) collaboration: Prospective combined analysis of phase III trials investigating duration of adjuvant therapy with the FOLFOX (FOLFOX4 or modified FOLFOX6) or XELOX (3 versus 6 months) regimen for patients with stage III colon cancer: Trial design and current status

André, T., Iveson, T., Labianca, R., Meyerhardt, J. A., Souglakos, I., Yoshino, T., Paul, J., Sobrero, A., Taieb, J., Shields, A. F., Ohtsu, A., Grothey, A. & Sargent, D. J., Sep 2013, In : Current Colorectal Cancer Reports. 9, 3, p. 261-269 9 p.

Research output: Contribution to journalArticle

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

Verslype, C., Van Cutsem, E., Dicato, M., Arber, N., Berlin, J. D., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Gruenberger, T., Haller, D., Haustermans, K., Hoff, P., Kerr, D., Labianca, R., Moore, M., Nordlinger, B., Ohtsu, A., Rougier, P., Scheithauer, W. & 4 others, Schmoll, H. J., Sobrero, A., Tabernero, J. & van de Velde, C., 2009, In : Annals of Oncology. 20, SUPPL.7, p. 1-6 6 p.

Research output: Contribution to journalArticle

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

Segaert, S., Tabernero, J., Chosidow, O., Dirschka, T., Elsner, J., Mancini, L., Maughan, T., Morere, J. F., Santoro, A., Sobrero, A., Van Cutsem, E. & Layton, A., Aug 2005, In : JDDG - Journal of the German Society of Dermatology. 3, 8, p. 599-606 8 p.

Research output: Contribution to journalArticle

The need for a new fluoropyrimidine in advanced gastric cancer treatment

Van Cutsem, E., Haller, D. G., Sobrero, A., Yamada, Y., Douillard, J. Y. & Moehler, M., Nov 2012, In : European Oncology and Haematology. 8, 4, p. 232-240 9 p.

Research output: Contribution to journalArticle

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Van Cutsem, E., Dicato, M., Arber, N., Benson, A., Cunningham, D., Diaz-Rubio, E., Glimelius, B., Goldberg, R., Haller, D., Haustermans, K., Koo-Kang, Y., Labianca, R., Lang, I., Minsky, B., Nordlinger, B., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J. & 2 others, Szawlowski, A. & van de Velde, C., Jun 2006, In : Annals of Oncology. 17, SUPPL. 6

Research output: Contribution to journalArticle

The oncosurgery approach to managing liver metastases from colorectal cancer: A multidisciplinary international consensus

Adam, R., De Gramont, A., Figueras, J., Guthrie, A., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., Sobrero, A., Tabernero, J., Teh, C., Van Cutsem, E. & Vauthey, J. N., 2012, In : The oncologist. 17, 10, p. 1225-1239 15 p.

Research output: Contribution to journalArticle

The potential role of tomudex in the treatment of advanced colorectal cancer

Sobrero, A. F., Mar 1997, In : Tumori. 83, 2, p. 576-580 5 p.

Research output: Contribution to journalArticle

The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients

Scartozzi, M., Sobrero, A., Gasparini, G., Berardi, R., Catalano, V., Graziano, F., Barni, S., Zaniboni, A., Beretta, G. D., Labianca, R. & Cascinu, S., Jul 2005, In : Oncology. 68, 2-3, p. 212-216 5 p.

Research output: Contribution to journalArticle

The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms.

Sobrero, A. & Bertino, J. R., 1984, In : Advances in Experimental Medicine and Biology. 176, p. 343-354 12 p.

Research output: Contribution to journalArticle

The two sides of 5-fluorouracil: Bolus and continuous infusion

Aschele, C., Guglielmi, A., Mori, A., Tixi, L., Bolli, E., Ciferri, E., Fazio, S., Municino, O. & Sobrero, A., 1995, In : Journal of Experimental and Clinical Cancer Research. 14, 2 SUPPL., p. 53-59 7 p.

Research output: Contribution to journalArticle

The urgent need to improve the tools to assess clinical benefit and value of cancer treatment

Sobrero, A., Puccini, A., Bregni, G. & Bruzzi, P., Sep 1 2017, In : European Journal of Cancer. 83, p. 324-328 5 p.

Research output: Contribution to journalArticle

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib

Faloppi, L., Bianconi, M., Giampieri, R., Sobrero, A., Labianca, R., Ferrari, D., Barni, S., Aitini, E., Zaniboni, A., Boni, C., Caprioni, F., Mosconi, S., Fanello, S., Berardi, R., Bittoni, A., Andrikou, K., Cinquini, M., Torri, V., Scartozzi, M. & Cascinu, S., 2015, In : Oncotarget. 6, 33, p. 35087-35094 8 p.

Research output: Contribution to journalArticle

Thromboembolic risk and survival with Khorana score in resected colorectal cancer patients: Subgroup analysis from the adjuvant TOSCA trial

Barni, S., Rosati, G., Zagonel, V., Pella, N., Banzi, M., Zampino, M. G., Di Bartolomeo, M., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., de Placido, S., Frassineti, L. G., Galli, F. & 1 others, Petrelli, F., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii194-viii195

Research output: Contribution to journalArticle

Open Access

Time-dependent interactions between 5-fluorouracil and mitomycin C on a human colon carcinoma cell line, HCT-8, in vitro

Russello, O., Romanini, A., Civalleri, D., Rosso, R., Nicolin, A. & Sobrero, A., 1989, In : European Journal of Cancer and Clinical Oncology. 25, 3, p. 571-572 2 p.

Research output: Contribution to journalArticle

Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research

De Feo, G., Frontini, L., Rota, S., Pepe, A., Signoriello, S., Labianca, R., Sobrero, A., De Placido, S. & Perrone, F., 2015, In : Journal of Medical Ethics. 41, 10, p. 799-803 5 p.

Research output: Contribution to journalArticle

Trattamento adiuvante del carcinoma del colon. Stato dell'arte e prospettive future.

Translated title of the contribution: Adjuvant therapy of colon cancer. State of the art and future perspectivesBarni, S., Cascinu, S., Foa, P., Frontini, L., Labianca, R., Luporini, G., Mandalà, M., Martignoni, G., Pancera, G., Sobrero, A. & Zaniboni, A., May 1999, In : Tumori. 85, 3

Research output: Contribution to journalArticle

TRATTAMENTO SEQUENZIALE CON METHOTREXATE 5-FLUOROURACILE + ACIDO FOLIN ICO IN PAZIENTI CON CARCINOMA DEL COLON RETTO RESISTENTI AL5-FLUOROURACILE

Translated title of the contribution: Sequential therapy with methotrexate and 5-fluorouracil in combination with folinic acid in advanced colorectal carcinomaVidili, M. G., Nobile, M. T., Aschele, C., Guglielmi Venturini, A. M., Sobrero, A. & Rosso, R., 1989, In : Folia Oncologica. 12, 3, p. 173-175 3 p.

Research output: Contribution to journalArticle

Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties

Grossi, F., Belvedere, O., Fasola, G., Ceschia, T., Meduri, S., Sibau, A., Sacco, C., Bazzocchi, M., Talmassons, G., Morelli, A., Barbone, F. & Sobrero, A., Aug 2004, In : Journal of Clinical Epidemiology. 57, 8, p. 804-808 5 p.

Research output: Contribution to journalArticle

Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer

Puglisi, F., Mansutti, M., Aprile, G., Minisini, A. M., Di Loreto, C., Bazzocchi, M., Londero, V., Cedolini, C., Gentile, G., Pizzolitto, S., Piga, A. & Sobrero, A., Jul 2004, In : Anticancer Research. 24, 4, p. 2487-2493 7 p.

Research output: Contribution to journalArticle

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A. F., Mazzola, G., Lambiase, A. & Bordignon, C., 2011, In : Annals of Oncology. 22, 4, p. 973-978 6 p.

Research output: Contribution to journalArticle

Ultime novità dall'ASCO 2000 in tema di carcinoma del colon-retto.

Translated title of the contribution: [Last news from ASCO 2000 in the topic of colorectal cancer] .Sobrero, A., May 2000, In : Tumori. 86, 3

Research output: Contribution to journalArticle

Uptake and metabolism of 5,8-dideazaisofolic acid in human colon carcinoma cells

Sobrero, A. F., McGuire, J. J. & Bertino, J. R., Mar 15 1988, In : Biochemical Pharmacology. 37, 6, p. 997-1001 5 p.

Research output: Contribution to journalArticle

Urgent need for a new staging system in advanced colorectal cancer

Poston, G. J., Figueras, J., Giuliante, F., Nuzzo, G., Sobrero, A. F., Gigot, J. F., Nordlinger, B., Adam, R., Gruenberger, T., Choti, M. A., Bilchik, A. J., Van Cutsem, E. J. D., Chiang, J. M. & D'Angelica, M. I., Oct 10 2008, In : Journal of Clinical Oncology. 26, 29, p. 4828-4833 6 p.

Research output: Contribution to journalArticle

VALUTAZIONE DELLA TOSSICITA DELLA DOXORUBICINA SULLE CELLULE STAMINALI EMOPOIETICHE NORMALI

Translated title of the contribution: Evaluation of Doxorubin toxicity on normal hemopoietic stem cellsMuzzulini, C., D'Amore, F. & Sobrero, A., 1981, In : Tumori. 67, 4, p. 293-300 8 p.

Research output: Contribution to journalArticle

Vatalanib in advanced colorectal cancer: Two studies with identical results

Sobrero, A. F. & Bruzzi, P., May 20 2011, In : Journal of Clinical Oncology. 29, 15, p. 1938-1940 3 p.

Research output: Contribution to journalArticle

Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcoma

Haupt, R., Perin, G., Dallorso, S., Garre, M. L. & Sobrero, A., 1989, In : Anticancer Research. 9, 2, p. 427-428 2 p.

Research output: Contribution to journalArticle

What is the Best Sequence of Targeted Agents in the Management of Advanced Colorectal Cancer

Sobrero, A. & Alessandro, P., Nov 2013, In : Annals of Oncology. 24, p. ix8

Research output: Contribution to journalArticle

Open Access

XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer

Cassidy, J., Tabernero, J., Twelves, C., Brunei, R., Butts, C., Conroy, T., Debrand, F., Figer, A., Grossmann, J., Sawada, N., Schöffski, P., Sobrero, A., Van Cutsein, E. & Díaz-Rubio, E., 2004, In : Journal of Clinical Oncology. 22, 11, p. 2084-2091 8 p.

Research output: Contribution to journalArticle

Book

Locoregional tumor therapy

Van Cutsem, E., Vogl, T. J., Orsi, F. & Sobrero, A., Jan 1 2015, Springer Berlin Heidelberg. 161 p.

Research output: Book/ReportBook

Locoregional Tumor Therapy

Van Cutsem, E., Vogl, T. J., Orsi, F. & Sobrero, A., Jan 1 2018, Springer International Publishing AG. 274 p.

Research output: Book/ReportBook

Chapter

Design and rationale for novel antifolates

Bertino, J. R., Sobrero, A., Mini, E., Moroson, B. A. & Cashmore, A., 1987, NCI Monographs. 5 ed. p. 87-91 5 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Differential efficacy of trimetrexate (2,4-diamino-6-methyl-(3,4,5-trimethoxyanilino)methyl) quinazoline, JB-11, TMQ) and methotrexate (MTX) on human colon carcinoma and human leukemia cells in vitro

Mini, E., Sobrero, A., Moroson, B. A. & Bertino, J. R., 1985, Proceedings of the American Association for Cancer Research. Vol. VOL. 26.

Research output: Chapter in Book/Report/Conference proceedingChapter

IDROCORTISONE E CELLULE STAMINALI PLURIPOTENTI EMOPOIETICHE

Translated title of the contribution: Hydrocortisone and pluripotent hemopoietic stem cellsMassa, G., Bogliolo, G., Lanfranco, E., Sobrero, A. & Pannacciulli, I., 1978, Archivio E. Maragliano di Patologia e Clinica. 1 ed. Vol. 34. p. 1-5 5 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico.

Translated title of the contribution: Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical caseBaldo, S., Rivoire, M., Sobrero, A., Comandini, D., Civalleri, D., Stella, M., Quaglia, F., Santoni, R., Malerba, M., Mariani, F. & DeCian, F., 2005, I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]. 3 ed. Vol. 4.

Research output: Chapter in Book/Report/Conference proceedingChapter